Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

Molecular Psychiatry

Volumn 4, Issue 3, 1999, Pages 286-289

  Tiihonen, J ^a,b   Hallikainen, T ^a   Lachman, H ^c   Saito, T ^c   Volavka, J ^d   Kauhanen, J ^a   Salonen, J T ^a   Ryynanen O P ^a   Koulu, M ^e   Karvonen, M K ^e   Pohjalainen, T ^e   Syvalahti E ^e   Hietala, J ^f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e UNIVERSITY OF TURKU   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alcoholism; Catechol O methyltransferase; COMT; Dopamine; Polymorphism; Substance abuse disorders

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FINLAND; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0033009868     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000509     Document Type: Article

References (32)

1. 1 Lachman HM, Papolus DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
2. 2 Syvänen A-C, Tilgmann C, Rinne J, Ulmanen I. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype wilh individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 1997; 7: 65-71.
3. 3 Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velocardio-facial syndrome. Am J Med Genet 1996; 67: 468-472.
4. 4 Kirov G, Murphy KC, Arranz MJ, Jones I, McCandles F, Kunugi H et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 1998; 3: 342-345.
5. 5 Papolus DR, Veit S, Faedda CL, Saito T, Lachman HM. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 1998; 3: 346-349.
6. 6 Strouss R, Bark N, Volavka J, Parsia SS, Lachman HM. Association of COMT codon 158 polymorphism aggressive and antisocial behavior in schizophrenia. Psychiatr Res 1997; 69: 71-77.
7. 7 Lachman HM, Nolan K, Mohr P, Saito T, Volavka J. Association between COMT genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 1998; 155: 835-837.
8. 8 Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J at al. Genotype determining low catechol-O-methyltransferase act as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 1997; 94; 4571-4575.
9. 9 Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol o-methyltransferase activity. Am J Psychiatry 1996; 153: 268-270.
10. 10 Gutiérrez B, Bertranpetit J, Guillamat R, Vallès V, Arranz MJ, Kerwin R et al. Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 1997; 154: 113-115.
11. 11 Biomed European Bipolar Collaborative Group. No association between bipolar disorder and alleles at a functional polymorphism in the COMT gene. Br J Psychiatry 1997; 170: 526-528.
12. 12 Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ et al. No evidence for an association of affective disorders with high-or low-activity allele of catechol-O-methyltransferase gene. Biol Psychiatry 1997; 42: 282-285.
13. 13 Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM et al. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet 1996; 6: 131-134.
14. 14 Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236: 410-416.
15. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacol Berl 1994; 116: 285-290.
16. 16 Volkov ND, Wang G-J, Fowler JS, Logan J, Hitzemann R, Ding Y-S et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: 1594-1598.
17. 17 Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen O-P et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1: 654-657.
18. 18 Tiihonen J, Vilkman H, Räsänen P, Ryynänen O-P, Hakko H, Bergman J et al. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. Mol Psychiatry 1998; 3: 156-161.
19. 19 Yoshimoto K, McBride WJ, Lumeng L, Li T-K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 1991; 9: 17-22.
20. 20 Kativas PW. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Revs 1993; 18: 75-113.
21. 21 Rossetti ZL, D'Aquila PS, Hmaidan Y, Gessa GL, Serra G. Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation. Eur J Pharmacol 1991; 201: 243-245.
22. 2 recepO tor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulaled dopamine synthesis. J Pharm Exp Ther 1992; 260: 872-878.
23. 23 Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS. β-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacol (Berl) 1991; 104: 51-56.
24. 24 Lang A, Harro J, Soosaar A, Koks S, Volke V, Oreland L et al. Role of N-methyl-D-aspartic acid and cholescystokinin receptors in apomorphine-induced aggressive behavior in rats. Naunyn Schmiedebergs Arch Pharmacol 1995; 351: 363-370.
25. 25 Koepp MJ, Gunn RN, Lawrence AD, Gunningham VJ, Dagher A, Tones T et al. Evidence for striatal dopamine release during a video game. Nature 1998; 393: 266-268.
26. 26 Cloninger C. The psychobiological regulation of social cooperation. Nature Med 1995; 1: 623-625.
27. 27 Selzer ML. The Michigan Alcoholism Screening Test: the quest for a new diagnostic: instrument. Am J Psychiatry 1971; 127: 1653-1658.
28. 28 Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. NEJM 1994; 330: 1549-1554.
29. 29 Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio ischaemic heart disease risk factor study. Ann Clin Res 1988; 20: 46-50.
30. 30 Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J 1988; 296: 1313-1316.
31. 31 Armitage P, Berry G. Statistical Methods in Medical Reseach, 2nd edn. Blackwell Scientific Publications: Oxford, 1987.
32. 32 Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994; 223: 1049-1054.